Characteristics That Predict Psoriatic Arthritis by the Classification Criteria for Psoriatic Arthritis in Patients With Juvenile Idiopathic Arthritis 18 Years After Disease Onset

Documenti analoghi

• Impact of Delay of Treatment With Disease‐Modifying Antirheumatic Drugs in Psoriatic Arthritis: The CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
  di: Philip J. Mease, et al.
  Pubblicazione: (2025)
• Impact of Variation in APOE on Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Sequencing and Genotyping in General Population Cohorts
  di: Katrine L. Rasmussen, et al.
  Pubblicazione: (2026)
• What Matters in Psoriatic Arthritis: A Comparison of Patient and Clinician Perspectives
  di: Philip J. Mease, et al.
  Pubblicazione: (2025)
• Improvements in Patient‐Reported Outcomes Through Six Months of Guselkumab Treatment in Patients With Active Psoriatic Arthritis: Real‐World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
  di: Philip J. Mease, et al.
  Pubblicazione: (2024)
• What Clinical Factors Affect Length of Transition to Psoriatic Arthritis in Patients With Psoriasis?
  di: Shashank Cheemalavagu, et al.
  Pubblicazione: (2024)